X. Pivot
Service d'Oncology
CHU J. Minjoz
Besançon
France
Name/email consistency: high
- Results of randomised phase II studies comparing S16020 with methotrexate in patients with recurrent head and neck cancer. Pivot, X., Awada, A., Gedouin, D., Kerger, J., Rolland, F., Cupissol, D., Caponigro, F., Comella, G., Lopez-Pousa, J.J., Guardiola, E., Giroux, B., Gérard, B., Schneider, M. Ann. Oncol. (2003)
- Result of two randomized trials comparing nolatrexed (Thymitaq) versus methotrexate in patients with recurrent head and neck cancer. Pivot, X., Wadler, S., Kelly, C., Ruxer, R., Tortochaux, J., Stern, J., Belpomme, D., Humblet, Y., Domenge, C., Clendeninn, N., Johnston, A., Penning, C., Schneider, M. Ann. Oncol. (2001)